期刊文献+

腹膜后淋巴结切除术在术中肉眼观察临床Ⅰ期卵巢上皮性癌中的意义 被引量:3

Significance of systematic lymphadenectomy in patients with macroscopic stageⅠepithelial ovarian carcinoma
下载PDF
导出
摘要 目的探讨腹膜后淋巴结切除在术中肉眼观察肿瘤局限于卵巢的临床Ⅰ期卵巢上皮性癌中的意义。方法回顾性分析1994年1月至2005年12月北京大学第一医院诊治的89例术中肉眼观察肿瘤局限于卵巢的Ⅰ期卵巢上皮性癌患者的临床资料。因各种原因未接受腹膜后淋巴结切除的45例为第Ⅰ组,接受全面严格分期手术的44例为第Ⅱ组,对两组的临床病理资料包括预后进行比较,并分析影响预后的因素。结果第Ⅱ组中淋巴结阳性者9例(20.4%),低分化癌的淋巴结转移率显著高于高、中分化癌。第Ⅰ组的2年、5年生存率分别为93.3%和91.1%,第Ⅱ组分别为95.4%和90.9%。两组预后差异无统计学意义(P>0.05)。COX逐步回归多因素分析显示,对于行分期手术者,分期对预后有影响,ⅠA期、ⅠB期、ⅠC期较ⅢC期预后好。结论腹膜后淋巴结切除术对术中肉眼观察肿瘤局限与卵巢的临床Ⅰ期卵巢上皮性癌的准确分期有价值,尤其对于低分化癌,但其并不改善患者预后。对于初次手术未行分期手术者,是否需再次手术清扫淋巴结值得探讨。 Objective To investigate the significance of systematic lymphadenectomy in patients with macroscopic stageⅠepithelial ovarian carcinoma.Methods Eighty-nine patients with macroscopic stage Ⅰ epithelial ovarian carcinoma were treated in Peking University First Hospital from January 1994 to December 2005. Patients were divided into two groups based on whether they had undergone lymphadenectomy or not. Forty-five patients who had not undergone lymphadenectomy were assigned into group Ⅰ and the other forty-four patients who had received lymphadenectomy were in group Ⅱ. The clinicopathological features were compared and factors associated with survival were identified.Results Nine patients (20.4%) were lymph node positive in group Ⅱ. The lymph node metastatic rate in patients with poor differentiated ovarian carcinoma was higher than those with well or moderate differentiated carcinoma. The 2 year and 5 year overall survival rate were 93.3% and 91.1%, respectively in group Ⅰ, and were 95.4% and 90.9% in group Ⅱ. The prognosis had no statistically difference between the two groups. Cox regression analysis identified that only stage was the independent prognostic factor for patients who had undergone systematic lymphadectomy. The prognosis in patients with stage ⅠA,ⅠB and ⅠC were better than that in stage ⅢC.Conclusions Lymph node excision is valuable for the accurate surgical staging of macroscopic stageⅠepithelial ovarian carcinoma, especially for the poor differentiated carcinoma. However it could not improve the prognosis of these patients. The significance of second surgery for patients without surgical staging at first operation needs more investigation.
出处 《中国妇产科临床杂志》 2010年第2期105-108,共4页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 腹膜后淋巴结切除 卵巢上皮癌 预后 lymph node excision ovarian carcinoma prognosis
  • 相关文献

参考文献8

  • 1Wu PC, Lang JH, Huang RL, et al. Lymph Node Metastasis and Retroperitoneal Lymphadenectomy in Ovirian Cancer. Bailliere's Clinical Obstetrics and Gynecology, 1989, 3: 143 - 155.
  • 2Scarabell IC, Gallo A, Zarrell IA, et al. Systematic pelvic and para - aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival. Gynecol Oncol, 1995, 56: 328-337.
  • 3Benedetti PP, Maggion IA, Hacker N, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes in optimally debulked advanced ovarian cancer: a randomized clinical trial. J National Cancer Inst, 2005, 97: 560 - 566.
  • 4Chid S, Eisenhauer EL, Lang J, et al. What is the optimal goal of primary cytoreductive surgery for bulky stage Ⅲ C epithelial ovarian carcinoma (EOC). Gynecol Oncoh 2006, 103: 559-564.
  • 5Chan JK, Munro EG, Cheungm K. Association of lymphade- nectomy and survival in stage Ⅰ ovarian cancer patients. Obstet Gynecol, 2007, 109:12-19.
  • 6Maggioni A, Benedetti PP, Anna TD, et al. Randomized study of systematic lymphadeneetomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer, 2006, 95: 699-704.
  • 7Cho YH, Kim DY, Kim JH, et al. Is complete surgical necessary in patients with stage Ⅰ mutinous epithelial ovarian tumors. Gynecol Oncol, 2006, 103.- 878-882.
  • 8Trope C, Kaern J. Adjuvant chemotherapy for early stage ovarian cancer: review of the literature. J Clin Oneol, 2007, 25: 2909- 2920.

同被引文献22

  • 1曾定元,沈铿,黄惠芳,吴鸣,潘凌亚,杨佳欣,郎景和.卵巢恶性肿瘤患者保留生育功能治疗的预后及相关因素分析[J].中华医学杂志,2005,85(36):2562-2565. 被引量:13
  • 2丁志明,谢幸.上皮性卵巢癌患者生育功能的保留[J].中国实用妇科与产科杂志,2006,22(4):247-249. 被引量:1
  • 3王文福,霍汝娟.Ⅰ期卵巢上皮性癌合理治疗模式的探讨[J].中华妇产科杂志,1996,31(7):387-389. 被引量:12
  • 4余冬青,李力.腹膜后淋巴结清扫在卵巢上皮癌治疗中的作用[J].广东医学,2007,28(9):1489-1491. 被引量:4
  • 5Maggioni A, Benedetti Panici P, Dell'Anna T, et al. Random- ised study of systematic lymphadenectomy in patients with epi- thelial ovarian cancer macroscopically confined to the pelvis [ J ]. Br J Cancer. 2006 Sep 18;95(6):699-704.
  • 6Kanat-Pektas M, Ozat M, Gungor T, et al. Complete lymph node dissection: is it essential for the treatment of borderline epithelial ovarian tumors? [J]. Arch Gynecol Obstet, 2011,283(4) :879- 884. doi: 10. 1007/s00404-010-1539-5.
  • 7Sakai K, Kajiyama H, Umezu T, et al. Is there any association between retroperitoncal lymphadenectomy and survival benefit in advanced stage epithelial ovarian carcinoma patients? [J]. J Ob- stet Gynaecol Res, 2012, 38 (7) : 1018-1023. doi : 10.1111/j. 1447-0756. 2011. 01826. x.
  • 8Abe A, Furumoto H, Irahara M, et al. The impact of systematic para-aortic and pelvic lymphadencctomy on survival in patients with optimally debulked ovarian cancer [ J ]. J Obstet Gynaecol Res, 2010, 36(5):1023-1030.
  • 9Classe JM, Cerato E, Boursier C, et al. Retroperitoneal lymph- adenectomy and survival of patients treated for an advanced ovari- an cancer: the CARACO trial[ J]. J Gynecol Obstet Biol Reprod (Paris) , 2011, 40(3) :201-4. doi: 10. 1016/j. jgyn. 2011. 02. 009.
  • 10许冬娣,汪艳.晚期上皮性卵巢癌腹膜后淋巴结清扫的临床价值[J].实用临床医药杂志,2013,17(9):156-158. 被引量:3

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部